These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28107378)

  • 41. Lack of Association between STAT4 Single Nucleotide Polymorphisms and Iranian Juvenile Rheumatoid Arthritis Patients.
    Aslani S; Mahmoudi M; Salmaninejad A; Poursani S; Ziaee V; Rezaei N
    Fetal Pediatr Pathol; 2017 Jun; 36(3):177-183. PubMed ID: 28524764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE).
    Ceccarelli F; Massafra U; Perricone C; Idolazzi L; Giacomelli R; Tirri R; Russo R; Pistone G; Ruscitti P; Parisi S; Sainaghi PP; Cacciapaglia F; Zullo A; Marino V; Migliore A; Valesini G
    Clin Exp Rheumatol; 2017; 35(1):24-32. PubMed ID: 27974105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Rheumatol Int; 2010 Mar; 30(5):661-6. PubMed ID: 19588142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML
    Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.
    Sode J; Vogel U; Bank S; Andersen PS; Thomsen MK; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2014; 9(6):e100361. PubMed ID: 24967817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis.
    Daha NA; Kurreeman FA; Marques RB; Stoeken-Rijsbergen G; Verduijn W; Huizinga TW; Toes RE
    Arthritis Rheum; 2009 May; 60(5):1255-60. PubMed ID: 19404967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.
    Vasilopoulos Y; Bagiatis V; Stamatopoulou D; Zisopoulos D; Alexiou I; Sarafidou T; Settas L; Sakkas L; Mamouris Z
    Clin Exp Rheumatol; 2011; 29(4):701-4. PubMed ID: 21813066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians.
    Palomino-Morales RJ; Rojas-Villarraga A; González CI; Ramírez G; Anaya JM; Martín J
    Genes Immun; 2008 Jun; 9(4):379-82. PubMed ID: 18432273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studying the Association between STAT4 Gene Polymorphism and Susceptibility to Rheumatoid Arthritis Disease: An Updated Meta-Analysis.
    Ebrahimiyan H; Mostafaei S; Aslani S; Jamshidi A; Mahmoudi M
    Iran J Immunol; 2019 Mar; 16(1):71-83. PubMed ID: 30864557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene.
    Ciccacci C; Perricone C; Ceccarelli F; Rufini S; Di Fusco D; Alessandri C; Spinelli FR; Cipriano E; Novelli G; Valesini G; Borgiani P; Conti F
    PLoS One; 2014; 9(11):e111991. PubMed ID: 25369137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.
    Kristensen LE; Kapetanovic MC; Gülfe A; Söderlin M; Saxne T; Geborek P
    Rheumatology (Oxford); 2008 Apr; 47(4):495-9. PubMed ID: 18316338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Suárez B; Hernández MV; Sanmartí R; Rego I; Celis R; Moll C; Pinto JA; Blanco FJ; Lozano F
    Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between SYVN1 and SEL1 genetic polymorphisms and remission in rheumatoid arthritis patients treated with TNF-α inhibitors: a machine learning approach.
    Kim W; Yeon HR; Kim JH; Kim JH; Kim JH; Kim HA; Jung JY; Kim J; Choi IA; Lee KE
    Immunol Res; 2023 Oct; 71(5):709-716. PubMed ID: 37119459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NHH; Andersen V
    Pharmacogenomics J; 2018 Jan; 18(1):81-86. PubMed ID: 27698401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis.
    Toms TE; Panoulas VF; Smith JP; Douglas KM; Metsios GS; Stavropoulos-Kalinoglou A; Kitas GD
    Ann Rheum Dis; 2011 Jun; 70(6):1025-32. PubMed ID: 21398331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies.
    Ai JW; Zhang S; Ruan QL; Yu YQ; Zhang BY; Liu QH; Zhang WH
    J Rheumatol; 2015 Dec; 42(12):2229-37. PubMed ID: 26472414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis.
    Liu C; Batliwalla F; Li W; Lee A; Roubenoff R; Beckman E; Khalili H; Damle A; Kern M; Furie R; Dupuis J; Plenge RM; Coenen MJ; Behrens TW; Carulli JP; Gregersen PK
    Mol Med; 2008; 14(9-10):575-81. PubMed ID: 18615156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Periodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort study.
    Chen HH; Chen DY; Lai KL; Chen YM; Chou YJ; Chou P; Lin CH; Huang N
    J Clin Rheumatol; 2013 Dec; 19(8):432-8. PubMed ID: 24263145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.
    Ranganathan P
    Pharmacogenomics; 2005 Jul; 6(5):481-90. PubMed ID: 16013998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.